Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,620 | 804 | 99.0% |
| Education | $132.36 | 12 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,659 | 110 | $0 (2024) |
| PFIZER INC. | $1,616 | 100 | $0 (2024) |
| ABBVIE INC. | $1,454 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,089 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,074 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $767.14 | 45 | $0 (2024) |
| Lilly USA, LLC | $694.49 | 43 | $0 (2024) |
| Amgen Inc. | $680.05 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $641.48 | 38 | $0 (2023) |
| Allergan, Inc. | $556.88 | 38 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,448 | 71 | PFIZER INC. ($320.37) |
| 2023 | $1,934 | 93 | PFIZER INC. ($321.22) |
| 2022 | $1,537 | 84 | Novo Nordisk Inc ($228.98) |
| 2021 | $1,824 | 106 | AbbVie Inc. ($389.04) |
| 2020 | $1,546 | 96 | Allergan, Inc. ($318.74) |
| 2019 | $1,667 | 101 | Boehringer Ingelheim Pharmaceuticals, Inc. ($242.17) |
| 2018 | $1,669 | 118 | AstraZeneca Pharmaceuticals LP ($211.75) |
| 2017 | $2,126 | 147 | AbbVie, Inc. ($317.93) |
All Payment Transactions
816 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Oncology | ||||||
| 11/26/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: VACCINES | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Neuromodulation | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Bone Health | ||||||
| 10/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Obesity | ||||||
| 09/19/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: PAIN | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: VACCINES | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,223 | 1,867 | $367,322 | $132,333 |
| 2022 | 17 | 1,483 | 2,320 | $455,838 | $157,707 |
| 2021 | 19 | 1,594 | 2,266 | $487,102 | $184,190 |
| 2020 | 15 | 1,501 | 2,282 | $492,701 | $153,769 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 325 | $98,800 | $33,100 | 33.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 96 | 96 | $63,552 | $27,143 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 341 | $70,246 | $22,925 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 133 | 133 | $47,614 | $19,114 | 40.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 22 | $14,410 | $5,201 | 36.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 15 | 108 | $15,876 | $4,486 | 28.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 54 | 54 | $8,964 | $4,018 | 44.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 90 | $17,370 | $4,016 | 23.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 96 | 96 | $7,008 | $3,324 | 47.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 110 | 110 | $5,610 | $2,315 | 41.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 55 | $4,015 | $1,905 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 131 | 217 | $2,118 | $1,762 | 83.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 23 | $3,473 | $1,086 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 65 | 74 | $4,958 | $778.71 | 15.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 34 | $1,292 | $551.48 | 42.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 53 | 58 | $928.00 | $244.62 | 26.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 13 | $494.00 | $210.60 | 42.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 18 | $594.00 | $153.09 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 322 | 552 | $167,808 | $54,694 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 333 | 565 | $116,390 | $39,774 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 219 | 219 | $78,069 | $32,900 | 42.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 23 | 151 | $22,197 | $6,950 | 31.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 23 | 123 | $23,739 | $6,688 | 28.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 24 | $15,720 | $6,166 | 39.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 45 | 45 | $7,335 | $3,081 | 42.0% |
About Dr. Jay Tyroler, M.D
Dr. Jay Tyroler, M.D is a Internal Medicine healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1962544700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Tyroler, M.D has received a total of $13,752 in payments from pharmaceutical and medical device companies, with $1,448 received in 2024. These payments were reported across 816 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($13,620).
As a Medicare-enrolled provider, Tyroler has provided services to 5,801 Medicare beneficiaries, totaling 8,735 services with total Medicare billing of $628,000. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Fairfax, VA
- Active Since 02/12/2007
- Last Updated 05/20/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962544700
Products in Payments
- Ozempic (Drug) $765.82
- JARDIANCE (Drug) $723.67
- XARELTO (Drug) $696.83
- FARXIGA (Drug) $653.45
- UBRELVY (Drug) $495.33
- ELIQUIS (Drug) $395.11
- NURTEC ODT (Drug) $361.83
- Synthroid (Drug) $348.66
- SYNTHROID (Drug) $335.35
- PREVNAR 20 (Biological) $313.72
- TRULICITY (Drug) $306.69
- VRAYLAR (Drug) $293.55
- TRADJENTA (Drug) $286.20
- SOLIQUA 100/33 (Biological) $284.99
- Rybelsus (Drug) $269.64
- CHANTIX (Drug) $251.55
- Wegovy (Drug) $222.21
- APLENZIN (Drug) $220.95
- EVENITY (Biological) $212.46
- JANUVIA (Drug) $210.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fairfax
Samim Enayat, Md, MD
Internal Medicine — Payments: $437,610
Brett Atwater, M.d, M.D
Internal Medicine — Payments: $355,531
Kathleen Harnden, M.d, M.D
Internal Medicine — Payments: $173,063
Dr. Daniel Kim, M.d., M.b.a, M.D., M.B.A
Internal Medicine — Payments: $124,814
Dr. Reza Zonozi, M.d, M.D
Internal Medicine — Payments: $118,319
Dr. Elizabeth Held, M.d, M.D
Internal Medicine — Payments: $84,557